Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination A US Cohort

被引:169
|
作者
Edelman, Alison [1 ]
Boniface, Emily R.
Benhar, Eleonora
Han, Leo
Matteson, Kristen A.
Favaro, Carlotta
Pearson, Jack T.
Darney, Blair G.
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
来源
OBSTETRICS AND GYNECOLOGY | 2022年 / 139卷 / 04期
关键词
STRESS;
D O I
10.1097/AOG.0000000000004695
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To assess whether coronavirus disease 2019 (COVID-19) vaccination is associated with changes in cycle or menses length in those receiving vaccination as compared with an unvaccinated cohort. METHODS: We analyzed prospectively tracked menstrual cycle data using the application "Natural Cycles." We included U.S. residents aged 18-45 years with normal cycle lengths (24-38 days) for three consecutive cycles before the first vaccine dose followed by vaccine-dose cycles (cycles 4-6) or, if unvaccinated, six cycles over a similar time period. We calculated the mean within-individual change in cycle and menses length (three prevaccine cycles vs first- and second-dose cycles in the vaccinated cohort, and the first three cycles vs cycles four and five in the unvaccinated cohort). We used mixed-effects models to estimate the adjusted difference in change in cycle and menses length between the vaccinated and unvaccinated cohorts. RESULTS: We included 3,959 individuals (vaccinated 2,403; unvaccinated 1,556). Most of the vaccinated cohort received the Pfizer-BioNTech vaccine (55%) (Moderna 35%, Johnson & Johnson/Janssen 7%). Overall, COVID-19 vaccine was associated with a less than 1-day change in cycle length for both vaccine-dose cycles compared with prevaccine cycles (first dose 0.71 day-increase, 98.75% CI 0.47-0.94; second dose 0.91, 98.75% CI 0.63-1.19); unvaccinated individuals saw no significant change compared with three baseline cycles (cycle four 0.07, 98.75% CI -0.22 to 0.35; cycle five 0.12, 98.75% CI -0.15 to 0.39). In adjusted models, the difference in change in cycle length between the vaccinated and unvaccinated cohorts was less than 1 day for both doses (difference in change: first dose 0.64 days, 98.75% CI 0.27-1.01; second dose 0.79 days, 98.75% CI 0.40-1.18). Change in menses length was not associated with vaccination. CONCLUSION: Coronavirus disease 2019 (COVID-19) vaccination is associated with a small change in cycle length but not menses length.
引用
收藏
页码:481 / 489
页数:9
相关论文
共 50 条
  • [41] Coronavirus disease 2019 (COVID-19) infection of healthcare personnel after complete COVID-19 vaccination
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (11): : 1757 - 1757
  • [42] COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease
    Dousari, Amin Sadeghi
    Moghadam, Majid Taati
    Satarzadeh, Naghmeh
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 2819 - 2828
  • [43] The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States
    Moghadas, Seyed M.
    Vilches, Thomas N.
    Zhang, Kevin
    Wells, Chad R.
    Shoukat, Affan
    Singer, Burton H.
    Meyers, Lauren Ancel
    Neuzil, Kathleen M.
    Langley, Joanne M.
    Fitzpatrick, Meagan C.
    Galvani, Alison P.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (12) : 2257 - 2264
  • [44] Factors affecting coronavirus disease 2019 (COVID-19) vaccination uptake in veterans
    Parsi, A.
    Verne, G.
    Zhou, Q.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S469 - S470
  • [45] Vaccination behavior in relation to coronavirus disease 2019 (COVID-19) A retrospective study
    Helbing, Alexander
    PRAVENTION UND GESUNDHEITSFORDERUNG, 2024,
  • [46] Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers
    Gilboa, Mayan
    Tal, Ilana
    Levin, Einav G.
    Segal, Shoshi
    Belkin, Ana
    Zilberman-Daniels, Tal
    Biber, Asaf
    Rubin, Carmit
    Rahav, Galia
    Regev-Yochay, Gili
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (10): : 1433 - 1438
  • [47] Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink
    Denoble, Anna E.
    Vazquez-Benitez, Gabriela
    Sheth, Sangini S.
    Ackerman-Banks, Christina M.
    DeSilva, Malini B.
    Zhu, Jingyi
    Daley, Matthew F.
    Getahun, Darios
    Klein, Nicola P.
    Vesco, Kimberly K.
    Irving, Stephanie A.
    Nelson, Jennifer
    Williams, Joshua T. B.
    Hambidge, Simon J.
    Donahue, James G.
    Weintraub, Eric S.
    Kharbanda, Elyse O.
    Lipkind, Heather S.
    OBSTETRICS AND GYNECOLOGY, 2024, 144 (02): : 215 - 222
  • [48] Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
    Bonow, Robert O.
    Fonarow, Gregg C.
    O'Gara, Patrick T.
    Yancy, Clyde W.
    JAMA CARDIOLOGY, 2020, 5 (07) : 751 - 753
  • [49] Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential Workers
    Mak, Josephine
    Khan, Sana
    Britton, Amadea
    Rose, Spencer
    Gwynn, Lisa
    Ellingson, Katherine D.
    Meece, Jennifer
    Feldstein, Leora R.
    Tyner, Harmony
    Edwards, Laura J.
    Thiese, Matthew S.
    Naleway, Allison
    Gaglani, Manjusha
    Solle, Natasha
    Burgess, Jefferey L.
    Lamberte, Julie Mayo
    Shea, Meghan
    Hunt-Smith, Taryn
    Caban-Martinez, Alberto
    Porter, Cynthia
    Wiegand, Ryan
    Rai, Ramona
    Hegmann, Kurt T.
    Hollister, James
    Fowlkes, Ashley
    Wesley, Meredith
    Philips, Andrew L.
    Rivers, Patrick
    Bloodworth, Robin
    Newes-Adeyi, Gabriella
    Olsho, Lauren E. W.
    Yoon, Sarang K.
    Saydah, Sharon
    Lutrick, Karen
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [50] Necessity of Coronavirus Disease 2019 (COVID-19) Vaccination in Persons Who Have Already Had COVID-19
    Shrestha, Nabin K.
    Burke, Patrick C.
    Nowacki, Amy S.
    Terpeluk, Paul
    Gordon, Steven M.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E662 - E671